$76.9 M

NEOS Mkt cap, 09-Nov-2018
Neos Therapeutics Net income (Q3, 2018)-12.7 M
Neos Therapeutics EBIT (Q3, 2018)-10.5 M
Neos Therapeutics Cash, 30-Sep-201816.6 M
Neos Therapeutics EV120.2 M

Neos Therapeutics Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017

Revenue

3.8m9.2m

Revenue growth, %

141%

Cost of goods sold

5.5m11.4m12.4m

Gross profit

(1.8m)(2.3m)

Gross profit Margin, %

(46%)(25%)

R&D expense

11.9m12.2m9.0m

General and administrative expense

7.5m12.6m13.8m

Operating expense total

19.4m24.8m22.8m

EBIT

(26.6m)(76.4m)(57.0m)

EBIT margin, %

(701%)(835%)

Interest expense

3.7m6.9m10.1m

Net Income

(30.8m)(83.3m)(66.2m)

Neos Therapeutics Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017

Cash

90.8m24.4m32.0m

Accounts Receivable

1.2m

Inventories

2.5m5.8m13.5m

Current Assets

98.2m55.3m82.6m

PP&E

5.1m7.1m8.2m

Total Assets

122.5m80.1m107.4m

Accounts Payable

4.8m7.8m11.5m

Short-term debt

8.0m4.9m896.0k

Current Liabilities

15.9m21.6m37.6m

Long-term debt

26.3m58.6m58.9m

Non-Current Liabilities

28.2m60.0m61.9m

Total Debt

34.2m63.5m59.8m

Total Liabilities

44.1m81.7m

Additional Paid-in Capital

195.3m198.8m274.6m

Retained Earnings

(116.8m)(200.1m)(266.4m)

Total Equity

78.4m(1.5m)7.9m

Debt to Equity Ratio

0.4 x-41 x

Debt to Assets Ratio

0.3 x0.8 x

Financial Leverage

1.6 x-51.8 x13.6 x

Neos Therapeutics Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017

Net Income

(30.8m)(83.3m)(66.2m)

Accounts Receivable

(2.2m)(7.5m)

Inventories

2.5m(3.2m)(7.7m)

Accounts Payable

4.8m3.0m3.0m

Cash From Operating Activities

(70.6m)(53.3m)

Cash From Investing Activities

(19.3m)(2.5m)

Cash From Financing Activities

23.6m63.4m

Interest Paid

2.9m6.8m

Free Cash Flow

(74.2m)(55.8m)

Neos Therapeutics Ratios

USDY, 2018

EV/EBIT

-11.5 x

EV/CFO

-3.3 x

EV/FCF

-3.2 x

Debt/Assets

0.8 x
Report incorrect company information

Neos Therapeutics Employee Rating

2.912 votes
Culture & Values
2.8
Work/Life Balance
2.8
Senior Management
2.6
Salary & Benefits
3.0
Career Opportunities
2.9
Source